Q8NEV9 (IL27A_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
April 3, 2013.
Version 65.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Interleukin-27 subunit alpha Short name=IL-27 subunit alpha Short name=IL-27-A Short name=IL27-A Alternative name(s): p28 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 243 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Cytokine with pro- and anti-inflammatory properties, that can regulate T-helper cell development, suppress T-cell proliferation, stimulate cytotoxic T-cell activity, induce isotype switching in B-cells, and that has diverse effects on innate immune cells. Among its target cells are CD4 T-helper cells which can differentiate in type 1 effector cells (TH1), type 2 effector cells (TH2) and IL17 producing helper T-cells (TH17). It drives rapid clonal expansion of naive but not memory CD4 T-cells. It also strongly synergizes with IL-12 to trigger interferon-gamma/IFN-gamma production of naive CD4 T-cells, binds to the cytokine receptor WSX-1/TCCR which appears to be required but not sufficient for IL-27-mediated signal transduction. IL-27 potentiate the early phase of TH1 response and suppress TH2 and TH17 differentiation. It induces the differentiation of TH1 cells via two distinct pathways, p38 MAPK/TBX21- and ICAM1/ITGAL/ERK-dependent pathways. It also induces STAT1, STAT3, STAT4 and STAT5 phosphorylation and activates TBX21/T-Bet via STAT1 with resulting IL12RB2 up-regulation, an event crucial to TH1 cell commitment. It suppresses the expression of GATA3, the inhibitor TH1 cells development. In CD8 T-cells, it activates STATs as well as GZMB. IL-27 reveals to be a potent inhibitor of TH17 cell development and of IL-17 production. Indeed IL-27 subunit p28 alone is also able to inhibit the production of IL17 by CD4 and CD8 T-cells. While IL-27 suppressed the development of proinflammatory Th17 cells via STAT1, it inhibits the development of anti-inflammatory inducible regulatory T-cells, iTreg, independently of STAT1. IL-27 has also an effect on cytokine production, it suppresses proinflammatory cytokine production such as IL2, IL4, IL5 and IL6 and activates suppressors of cytokine signaling such as SOCS1 and SOCS3. Apart from suppression of cytokine production, IL-27 also antagonizes the effects of some cytokines such as IL6 through direct effects on T-cells. Another important role of IL-27 is its antitumor activity as well as its antiangiogenic activity with activation of production of antiangiogenic chemokines such as IP-10/CXCL10 and MIG/CXCL9. In vein endothelial cells, it induces IRF1/interferon regulatory factor 1 and increase the expression of MHC class II transactivator/CIITA with resulting up-regulation of major histocompatibility complex class II. IL-27 also demonstrates antiviral activity with inhibitory properties on HIV-1 replivation. Ref.1 Ref.5 Ref.6 Ref.7 |
| Subunit structure | Heterodimer with IL27B/EBI3. IL-27 is a heterodimer composed IL27 and EBI3. EBI3 is also a component of the IL-12 heterodimer. Ref.1 |
| Subcellular location | Secreted. Note: Does not seem to be secreted without coexpression of EBI3. Ref.1 |
| Tissue specificity | Expressed in monocytes and in placenta. Ref.1 |
| Induction | Transiently induced by bacterial lipopolysaccharides (LPS) stimulation in monocytes. Ref.1 |
| Post-translational modification | O-glycosylated Probable. Ref.1 |
| Sequence similarities | Belongs to the IL-6 superfamily. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 28 | 28 | Potential | ||||||
| Chain | 29 – 243 | 215 | Interleukin-27 subunit alpha | PRO_0000320139 | |||||
Regions | |||||||||
| Compositional bias | 164 – 176 | 13 | Glu-rich | ||||||
Natural variations | |||||||||
| Natural variant | 59 | 1 | S → A. Ref.4 Ref.9 Corresponds to variant rs17855750 [ dbSNP | Ensembl ]. | VAR_039140 | |||||
| Natural variant | 119 | 1 | L → P. Ref.1 Ref.9 Corresponds to variant rs181206 [ dbSNP | Ensembl ]. | VAR_039141 | |||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells." Pflanz S., Timans J.C., Cheung J., Rosales R., Kanzler H., Gilbert J., Hibbert L., Churakova T., Travis M., Vaisberg E., Blumenschein W.M., Mattson J.D., Wagner J.L., To W., Zurawski S., McClanahan T.K., Gorman D.M., Bazan J.F. Kastelein R.A.Immunity 16:779-790(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, GLYCOSYLATION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, INDUCTION, SUBUNIT, VARIANT PRO-119. |
| [2] | Livingston R.J., Shaffer T., McFarland I., Nguyen C.P., Stanaway I.B., Rajkumar N., Johnson E.J., da Ponte S.H., Willa H., Ahearn M.O., Bertucci C., Acklestad J., Carroll A., Swanson J., Gildersleeve H.I., Nickerson D.A. Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [3] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT ALA-59. Tissue: Lung. |
| [5] | "IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells." Hibbert L., Pflanz S., De Waal Malefyt R., Kastelein R.A. J. Interferon Cytokine Res. 23:513-522(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [6] | "Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27." Fakruddin J.M., Lempicki R.A., Gorelick R.J., Yang J., Adelsberger J.W., Garcia-Pineres A.J., Pinto L.A., Lane H.C., Imamichi T. Blood 109:1841-1849(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [7] | "Interleukin-27 upregulates major histocompatibility complex class II expression in primary human endothelial cells through induction of major histocompatibility complex class II transactivator." Feng X.M., Chen X.L., Liu N., Chen Z., Zhou Y.L., Han Z.B., Zhang L., Han Z.C. Hum. Immunol. 68:965-972(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [8] | "The biology and therapeutic potential of interleukin 27." Batten M., Ghilardi N. J. Mol. Med. 85:661-672(2007) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [9] | "Identification of polymorphisms in human interleukin-27 and their association with asthma in a Korean population." Chae S.-C., Li C.-S., Kim K.M., Yang J.Y., Zhang Q., Lee Y.-C., Yang Y.-S., Chung H.-T. J. Hum. Genet. 52:355-361(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ALA-59 AND PRO-119. |
| + | Additional computationally mapped references. |
Web resources
| Wikipedia Interleukin-27 entry |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AY099296 mRNA. Translation: AAM34498.1. EF064720 Genomic DNA. Translation: ABK41903.1. CH471279 Genomic DNA. Translation: EAW52277.1. BC062422 mRNA. Translation: AAH62422.1. |
| IPI | IPI00302598. |
| RefSeq | NP_663634.2. NM_145659.3. |
| UniGene | Hs.528111. |
3D structure databases | |
| ProteinModelPortal | Q8NEV9. |
| ModBase | Search... |
Protein-protein interaction databases | |
| DIP | DIP-59473N. |
| STRING | 9606.ENSP00000349365. |
PTM databases | |
| PhosphoSite | Q8NEV9. |
Polymorphism databases | |
| DMDM | 182701368. |
Proteomic databases | |
| PaxDb | Q8NEV9. |
| PRIDE | Q8NEV9. |
Protocols and materials databases | |
| DNASU | 246778. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000356897; ENSP00000349365; ENSG00000197272. |
| GeneID | 246778. |
| KEGG | hsa:246778. |
| UCSC | uc002dqc.3. human. |
Organism-specific databases | |
| CTD | 246778. |
| GeneCards | GC16M028511. |
| H-InvDB | HIX0038580. |
| HGNC | HGNC:19157. IL27. |
| HPA | CAB024722. |
| MIM | 608273. gene. |
| neXtProt | NX_Q8NEV9. |
| PharmGKB | PA134870478. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG45660. |
| HOGENOM | HOG000113043. |
| HOVERGEN | HBG097312. |
| InParanoid | Q8NEV9. |
| OMA | PAQVSWP. |
| OrthoDB | EOG42NJ1B. |
| PhylomeDB | Q8NEV9. |
Enzyme and pathway databases | |
| Pathway_Interaction_DB | il27pathway. IL27-mediated signaling events. |
Gene expression databases | |
| ArrayExpress | Q8NEV9. |
| Bgee | Q8NEV9. |
| CleanEx | HS_IL27. |
| Genevestigator | Q8NEV9. |
Family and domain databases | |
| InterPro | IPR026207. IL27-A. [Graphical view] |
| PANTHER | PTHR20879. PTHR20879. 1 hit. |
| ProtoNet | Search... |
Other | |
| GenomeRNAi | 246778. |
| NextBio | 91980. |
| SOURCE | Search... |
Entry information
| Entry name | IL27A_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q8NEV9 Secondary accession number(s): A0N0L2, Q6P676 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 16 Human chromosome 16: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
